It was supposed to be an easy form of permanent birth control, one that can be performed in a doctor’s office. No surgery, no hormones, no down time. But now thousands of women who’ve had the procedure claim they’re suffering from severe side effects, and they’re coming forward to warn others about the Essure procedure. NBC Charlotte's Katie Killen has the report. Watch the video for the story.
Read the full statement by Bayer on Essure:
At Bayer, we care about patients and take the safety of our products very seriously. We are saddened to hear of any serious health condition affecting a patient using one of our products, irrespective of the cause. Essure was approved by the FDA in 2002, and has a well-documented benefit-risk profile, with over 400 peer-reviewed publications and abstracts supporting Essure’s safety, efficacy and cost-effectiveness. Approximately 750,000 women worldwide rely upon the Essure procedure for permanent birth control. A recent practice bulletin issued by the American College of Obstetricians and Gynecologists (ACOG) has recognized that hysteroscopic tubal occlusion for sterilization has high efficacy and low procedure-related risk, cost, and resource requirements.
No form of birth control is without risk or should be considered appropriate for every woman. It is important that women discuss the risks and benefits of any birth control option with their physicians.
Thank you again for allowing us to provide our commentary.
Head, U.S. External Communications